Evidence map›Paper›PMID 41017958›Full record

ReviewCerebral circulation - cognition and behavior2025

From dementia prevention research to global FINGER-based multi-domain interventions and implementation strategies.

Shireen Sindi, Manasa Shanta Näsholm, Mariagnese Barbera, Charlotta Thunborg, Yunfei Li, Linus Jönsson, Francesca Mangialasche, Chengxuan Qiu, Miia Kivipelto

Registry-linked trialAbstract readReview
In one paragraph

Review in Cerebral circulation - cognition and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07730671 (Evaluation of the Long-Term Cognitive, Biological, and Lifestyle Effects of a Multimodal Intervention for Preventing Cognitive Decline in APOE-ε4 Carriers With Subjective Cognitive Decline), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07730671 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of the Long-Term Cognitive, Biological, and Lifestyle Effects of a Multimodal Intervention for Preventing Cognitive Decline in APOE-ε4 Carriers With Subjective Cognitive Decline

TypeobservationalSponsorBarcelonabeta Brain Research Center, Pasqual Maragall FoundationRan2026 to 2028Enrolled121ConditionsSubjective Cognitive Decline (SCD)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. The success-failure inversion in modern medicine.Frontiers in public health · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shireen SindiDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Manasa Shanta NäsholmDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Mariagnese BarberaAgeing Epidemiology Research Unit (AGE), School of Public Health, Faculty of Medicine, Imperial College London, UK.
Charlotta ThunborgDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Yunfei LiDivision of Neurogeriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Linus JönssonDivision of Neurogeriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Francesca MangialascheDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Chengxuan QiuAging Research Center, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Miia KivipeltoDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demographic transition during the recent decades has resulted in an increase in older adults globally. Cognitive impairment and dementia are the leading causes of functional disability, which significantly decreases the quality of life and increases the use of healthcare resources and societal costs. The goal of this narrative review is to summarize the recent evidence on the epidemiology of cognitive disorders and dementia, their societal burdens, the potential of multidomain lifestyle interventions, the implementation of such interventions and the cost-effectiveness of dementia prevention. Our review demonstrates that although population-based studies have shown a stable or decreasing prevalence of dementia during the recent decades in Europe and North America, an opposite trend has been observed in other regions, including low- and middle-income countries where there is an increasing prevalence. Considering the multifactorial etiology of dementia, to date, multidomain lifestyle interventions simultaneously targeting several risk factors, such as the FINGER trial, have been most effective. Such interventions have important beneficial effects for cognition and other outcomes including physical function, reduced multimorbidity and use of healthcare resources, while proving to be cost-effective. More recent efforts have focused on tailoring and adapting multidomain lifestyle interventions to various global regions, while taking into consideration local infrastructures, cultural norms and specific needs. Such global efforts have been coordinated through the World-Wide FINGERS Network, which aims to harmonize trial methodologies to investigate the effects of FINGER-based interventions in different populations to acquire robust globally relevant evidence. Similarly, there is a need to adapt dementia risk prediction models to various geographic settings. For the wider implementation of multidomain lifestyle interventions, different societal and healthcare levels need to be included, such as the community level, primary care, and specialist (e.g. memory) clinics, and such initiatives are currently being tested in Nordic countries. Taken together, effective multidomain risk reduction programs have the potential to significantly reduce the economic and societal burdens of dementia.

Indexed as

DementiaGlobalImplementationMultidomain interventionsPrevention

Identifiers

PMID41017958
PMCPMC12464548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.